Page last updated: 2024-10-18

hydroxymethylbilane and Protoporphyria, Erythropoietic

hydroxymethylbilane has been researched along with Protoporphyria, Erythropoietic in 1 studies

Protoporphyria, Erythropoietic: An autosomal dominant porphyria that is due to a deficiency of FERROCHELATASE (heme synthetase) in both the LIVER and the BONE MARROW, the last enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and COPROPORPHYRINS in the feces.

Research Excerpts

ExcerptRelevanceReference
"Mutations in the uroporphyrinogen III synthase (UROS) gene cause congenital erythropoietic porphyria (CEP), an autosomal-recessive inborn error of erythroid heme biosynthesis."3.77ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. ( Badenas, C; Beaumont, C; Clayton, J; de Verneuil, H; Delaby, C; Deybach, JC; Ducamp, S; Ferreira, GC; Ged, C; Gouya, L; Herrero, C; Lyoumi, S; Puy, H; To-Figueras, J, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
To-Figueras, J1
Ducamp, S1
Clayton, J1
Badenas, C1
Delaby, C1
Ged, C1
Lyoumi, S1
Gouya, L1
de Verneuil, H1
Beaumont, C1
Ferreira, GC1
Deybach, JC1
Herrero, C1
Puy, H1

Other Studies

1 other study available for hydroxymethylbilane and Protoporphyria, Erythropoietic

ArticleYear
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    Blood, 2011, Aug-11, Volume: 118, Issue:6

    Topics: 5-Aminolevulinate Synthetase; Amino Acid Sequence; Anemia, Sideroblastic; Base Sequence; Child, Pres

2011